Head of Manufacturing
NewLimit
This listing was originally posted on NewLimit's careers page. Formulate is an equal opportunity job aggregator and is not involved in the hiring process. Where salary information is estimated, it is derived from BLS industry benchmarks and may differ from actual compensation.
Upgrade to Pro to access the AI-generated 'Read before applying' briefing and other premium pharma intelligence.
Upgrade to Pro — $25/moNewLimit is a biotechnology company working to radically extend human healthspan. We’re developing medicines to treat aging and age-related diseases by reprogramming the epigenome, a new therapeutic mechanism to restore regenerative potential in aged and diseased cells. We leverage functional genomics, pooled perturbation screening, and artificial intelligence systems to unravel the biology of aging and disease using experiments of unprecedented scale.
NewLimit is recruiting a Head of Manufacturing to lead drug substance and product chemistry, manufacturing, and controls (CMC). We are creating a new class of epigenetic reprogramming medicines for aging that build upon LNP and mRNA technology. Our initial assets are progressing through the complex manufacturing cascade that these modalities entail.
In this role, you will orchestrate manufacturing for some of the first reprogramming medicines to enter human trials. You will serve as the company’s resident expert in manufacturing & controls, and manage a team of talented scientists & engineers to achieve your goals.
As part of the role you will:
Compensation for the role will depend on a number of factors, including a candidate’s qualifications, skills, competencies, and experience. NewLimit offers a competitive benefits package, which includes a 401k, healthcare coverage, and 20 days of PTO. Learn more at: https://www.newlimit.com/careers
Explore related positions you might be interested in
We'll notify you when matching roles are posted.
Interviewed at NewLimit?
Help others prepare — share your experience anonymously.
BIOTECHNOLOGY
Epigenetic Reprogramming Therapies
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo